It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
The surface proteins of the mumps virus, the fusion protein (F) and haemagglutinin-neuraminidase (HN), are key factors in mumps pathogenesis and are important targets for the immune response during mumps virus infection. We compared the predicted amino acid sequences of the F and HN genes from Dutch mumps virus samples from the pre-vaccine era (1957–1982) with mumps virus genotype G strains (from 2004 onwards). Genotype G is the most frequently detected mumps genotype in recent outbreaks in vaccinated communities, especially in Western Europe, the USA and Japan. Amino acid differences between the Jeryl Lynn vaccine strains (genotype A) and genotype G strains were predominantly located in known B-cell epitopes and in N-linked glycosylation sites on the HN protein. There were eight variable amino acid positions specific to genotype A or genotype G sequences in five known B-cell epitopes of the HN protein. These differences may account for the reported antigenic differences between Jeryl Lynn and genotype G strains. We also found amino acid differences in and near sites on the HN protein that have been reported to play a role in mumps virus pathogenesis. These differences may contribute to the occurrence of genotype G outbreaks in vaccinated communities.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details

1 Centre for Infectious Disease Control, RIVM, Bilthoven, The Netherlands (GRID:grid.31147.30) (ISNI:0000 0001 2208 0118); Department of Viroscience, Erasmus MC, Rotterdam, The Netherlands (GRID:grid.5645.2) (ISNI:000000040459992X); University of Pennsylvania, Microbiology Department, Perelman School of Medicine, Philadelphia, USA (GRID:grid.25879.31) (ISNI:0000 0004 1936 8972)
2 Sciensano, National Reference Centre for Measles, Mumps and Rubella, Brussels, Belgium (GRID:grid.25879.31); Ghent University, Department of Biochemistry, Ghent, Belgium (GRID:grid.5342.0) (ISNI:0000 0001 2069 7798); VIB-UGent Center for Medical Biotechnology, VIB, Ghent, Belgium (GRID:grid.11486.3a) (ISNI:0000000104788040)
3 Sciensano, National Reference Centre for Measles, Mumps and Rubella, Brussels, Belgium (GRID:grid.11486.3a)
4 Ghent University, Department of Biochemistry, Ghent, Belgium (GRID:grid.5342.0) (ISNI:0000 0001 2069 7798); VIB-UGent Center for Medical Biotechnology, VIB, Ghent, Belgium (GRID:grid.11486.3a) (ISNI:0000000104788040)
5 Centre for Infectious Disease Control, RIVM, Bilthoven, The Netherlands (GRID:grid.31147.30) (ISNI:0000 0001 2208 0118)
6 Centers for Disease Control and Prevention (CDC), National Center for Immunization and Respiratory Diseases, Atlanta, USA (GRID:grid.416738.f) (ISNI:0000 0001 2163 0069)
7 Ghent University, Center for Vaccinology, Ghent, Belgium (GRID:grid.5342.0) (ISNI:0000 0001 2069 7798)
8 Centre for Infectious Disease Control, RIVM, Bilthoven, The Netherlands (GRID:grid.31147.30) (ISNI:0000 0001 2208 0118); Department of Viroscience, Erasmus MC, Rotterdam, The Netherlands (GRID:grid.5645.2) (ISNI:000000040459992X)